GSX Launches New Office 365 End-User Experience Analysis at Microsoft Ignite
Sep 21, 2017 11:55 am UTC| Business
ORLANDO, Fla., Sept. 21, 2017 -- GSX Solutions, the leading provider of monitoring and management solutions for Office 365 messaging, collaboration, and mobility services, today announced its new Digital Experience...
Inovalon Announces Agreement with Daiichi Sankyo, Inc. to Support Outcomes-Based Contracting
Sep 21, 2017 11:55 am UTC| Business
BOWIE, Md., Sept. 21, 2017 -- Inovalon (NASDAQ:INOV), a leading technology company providing advanced, cloud-based platforms empowering a data-driven transformation from volume-based to value-based models across the...
Sep 21, 2017 11:53 am UTC| Business
Albany - NY, Sept. 21, 2017 -- “The ongoing expansion in the oil and gas industry across the world is the main factor behind the significant growth of the global market for unmanned underwater vehicles,” says a TMR...
Asure Software’s Annual C3 User Conference to be Held at Walt Disney’s Coronado Resort
Sep 21, 2017 11:45 am UTC| Business
AUSTIN, Texas, Sept. 21, 2017 -- Asure Software, (NASDAQ:ASUR), a leading provider in human capital management and workspace management software announced today that their annual C3 user conference will be held at Walt...
Sep 21, 2017 11:45 am UTC| Business
LOS ANGELES, Sept. 21, 2017 -- Nova LifeStyle, Inc. (NASDAQ:NVFY) or (the “Company,” "Nova"), a U.S.-based innovative designer and distributor of modern LifeStyle products is pleased to announce that based upon market...
Orphan Drugs Market to reach US$318.5 bn by 2025, globally: Transparency Market Research
Sep 21, 2017 11:33 am UTC| Business
Albany - NY, Sept. 21, 2017 -- As per an analyst at TMR, the global orphan drugs market is anticipated to expand at a significant growth rate on account of a number of factors. Amongst all, high return on...
U.S. FDA Grants Orphan Drug Designation for ATB200/AT2221 for Pompe Disease
Sep 21, 2017 11:30 am UTC| Business
CRANBURY, N.J., Sept. 21, 2017 -- Amicus Therapeutics (Nasdaq:FOLD) today announced the U.S. FDA has granted orphan drug designation to ATB200/AT2221 for the treatment of Pompe disease, an inherited lysosomal storage...